Infinity Pharmaceuticals Inc (INFI) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Infinity Pharmaceuticals Inc   (NASDAQ: INFI)


Infinity Pharmaceuticals Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Infinity Pharmaceuticals Inc 's ROA in the second quarter of 2023?
Infinity Pharmaceuticals Inc recorded a cumulative net loss of $-41 million during 12 months ending in the second quarter of 2023, resulting in a negative return on assets (ROA) of -112.53%.

However, within the Healthcare sector 961 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 5077, from total ROA ranking in the first quarter of 2023 at 5131.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Total Assets Change -65.38 % -58.41 % -50.03 % -45.31 % -39.78 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -41 -43 -44 -47 -47
Return On Assets (TTM) -112.53 % -92.45 % -77.76 % -69.17 % -59.7 %
INFI's Total Ranking # 5077 # 5131 # 5796 # 5073 # 5131
Total Assets (TTM) in million 21 30 42 52 62
Seq. Total Assets Change -28.96 % -28.84 % -18.24 % -16.24 % -14.66 %
Seq. Net Income Change - - - - -

INFI's 5 Years Annual ROA >> Back to INFI Management Effectiveness >> Compare INFI ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 460
Sector # 962
Overall # 4971

Return On Assets Statistics
High Average Low
5.97 %
-49.92 %
-113.02 %
(Jun 30 2016)   (Jun 30 2023)





Financial Statements
Infinity Pharmaceuticals Inc 's Assets $ 21 million INFI's Balance sheet
Infinity Pharmaceuticals Inc 's Income $ -10 million Quarterly INFI's Income Statement
INFI's Income by Division See INFI's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -50.03 % 115.33 % -19.78 % -18.6 % 1.45 %
Total Assets in million 42 85 39 49 60
Y / Y Net Income Change - - - - -
Net Income in million -44 -45 -40 -47 -11
Annual Return On Assets -104.87 % -53.46 % -102.98 % -96.01 % -18.69 %

INFI's 5 Years Annual ROA >> Back to INFI Management Effectiveness >> Compare INFI ROA to its Competitors



More Return On Assets Ratios
INFI's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
INFI's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for INFI's Competitors
Subscribers only: Roa for Infinity Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for INFI's Customers

You may also want to know
INFI's Roi INFI's Inventory Turnover Ratio INFI's Growth Rates INFI's Dividend Comparisons
INFI's Profitability Ratios INFI's Asset Turnover Ratio INFI's Dividend Growth
INFI's Roe INFI's Valuation Ratios INFI's Financial Strength Ratios INFI's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.